Hypnosis for smoking: what the quit-rate evidence says

What would convincing evidence look like?

A person leaving a session without wanting a cigarette is an encouraging moment, but it is not the same outcome as remaining smoke-free a year later. Stronger research defines success in advance, follows everyone assigned to treatment, compares credible alternatives, and verifies smoking status where possible.

Before accepting a headline success rate, ask who was counted. A rate based only on people who answer a follow-up survey can be misleading if people who resumed smoking are less likely to respond. Ask about the follow-up duration and whether the result is continuous abstinence or merely no smoking during the preceding week.

What the Cochrane review concluded

The 2019 Cochrane review included 14 studies and 1,926 participants. Six trials comparing hypnosis with behavioral support matched for contact time, involving 957 people, gave a pooled risk ratio of 1.21 (95% CI 0.91–1.61). Because the interval includes 1, this comparison did not establish a benefit. Evidence certainty was low.^[1]

This is uncertainty, not proof that hypnosis never helps anyone. The review found substantial limitations in the underlying studies and insufficient evidence that hypnosis was more effective than other behavioral support or unassisted quitting. Its search ended in 2018, so later trials need consideration too.^[1]

A newer head-to-head trial

A 2024 trial randomized 360 smokers to six weekly, 90-minute group sessions of hypnotherapy or CBT. The primary outcome was continuous abstinence over 12 months, with carbon-monoxide verification at assessment points. Rates were 15.0% with hypnosis and 15.6% with CBT; the difference was not significant.^[2]

The trial supports a more restrained conversation than either a cure claim or a blanket dismissal. It studied substantial therapist contact and a specific program. It did not compare a consumer audio recording with medication plus counseling, and its result should not be extended to those comparisons.^[2]

Build a quit plan around established support

The WHO’s 2024 guideline emphasizes evidence-based behavioral interventions and pharmacological treatments. A clinician or tobacco-cessation service can help you choose support suited to your health, preferences, and previous attempts. Interest in hypnosis need not prevent that conversation.^[3]

What to ask a hypnosis provider

• What is your definition of a successful quit, and when do you measure it?
• Does your success rate include people who dropped out or could not be reached?
• Was this exact program tested in a randomized trial?
• What happens if cravings persist or I resume smoking?
• Will you support counseling and clinician-recommended medication alongside your program?

A practical rehearsal might involve imagining your usual smoking break and choosing a different action in advance. That is an example of a planning exercise, not a validated stand-alone treatment. The relevant test is whether it supports the broader quit attempt, including the parts that happen when you are tired, distracted, or under pressure.

It is reasonable to care about whether a program feels engaging and affordable. Those features may influence whether you use it, but they should not be confused with evidence that it produces higher quit rates. A transparent provider should be comfortable discussing both preferences and uncertainty.

What the evidence means for Hypnova

The research cited here does not establish Hypnova as a smoking-cessation treatment. NIH’s overview likewise treats smoking evidence separately from findings for other conditions.^[4] General relaxation or motivation practice should not inherit the quit rates of a clinical program. Choose support based on the outcome you need: a sustained quit, not simply a persuasive session.

Want to try hypnotherapy for quitting smoking? Explore free smoking cessation hypnosis sessions in Hypnova.